SCHEMBL26316121

SCHEMBL26316121

COC(=O)c1ccc(-c2ccc(C)cc2OC)nn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALPL P05186 2/20 0.45
CYP46A1 Q9Y6A2 1/20 0.45
MAPT P10636 4/20 0.40
HTT P42858 2/20 0.40
HSP90AA1 P07900 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
NOTUM Q6P988 1/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
MAPK1 P28482 2/20 0.39
ACHE P22303 1/20 0.39
MAOB P27338 2/20 0.38
EPHX1 P07099 1/20 0.37
GAA P10253 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25403968 0.82 CFTR (0.46) MAPTKDM4E
SCHEMBL26316100 0.77 ACHE (0.47) MAPTHTTHSP90AA1ALDH1A1KDM4E
SCHEMBL14022297 0.76 RAB9A (0.51) ALPLCYP46A1MAPTNPSR1ALDH1A1
SCHEMBL22296047 0.75 KDM4E (0.44) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL930708 0.75 ALPL (0.47) ALPLCYP46A1MAPTRAB9AMAPK1
SCHEMBL26316117 0.74 ACHE (0.41) MAPTHTTALDH1A1MEN1KMT2A
SCHEMBL26316119 0.74 L3MBTL1 (0.41) CYP46A1MAPTHTTNPSR1ALDH1A1
SCHEMBL25450659 0.73 CYP46A1 (0.59) CYP46A1MAPTHTTHSP90AA1NPSR1
SCHEMBL29442775 0.73 MAPK1 (0.57) MAPTNPSR1ALDH1A1MEN1KMT2A
SCHEMBL1456298 0.73 MAPK1 (0.57) MAPTNPSR1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295113-A1 NLRP3 MODULATORS ZOMAGEN BIOSCIENCES LTD 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295113-A1 NLRP3 MODULATORS NLRP3, NLRP1, NOD1 ALPL 4667/4885CYP46A1 353/4885MAPT 382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.